Antibody data
- Antibody Data
- Antigen structure
- References [30]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 11858-1-AP - Provider product page

- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#11858-1-AP, RRID:AB_2234673
- Product name
- Galectin-1 antibody
- Antibody type
- Polyclonal
- Description
- Galectin-1 antibody (Cat. #11858-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IF, IHC, WB, ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Spatial Transcriptomics Meets Histochemistry: Insights from Glioblastoma as a Model System.
Cancer-associated fibroblasts promote immune evasion in pancreatic cancer via miR-181b-5p/STING/LGALS1 pathway.
Multi-omics analysis identified LGALS1 (Galectin-1) as a novel therapeutic target for clear cell renal cell carcinoma via targeting epithelial or endothelial cells.
Molecular landscape of atherosclerotic plaque progression: insights from proteomics, single-cell transcriptomics and genomics.
Impact of galectin-1's redox state on its lectin activity and monomer-dimer equilibrium. Focusing on oxidized Gal-1.
Galectin-1: An important regulator in myeloid differentiation and acute myeloid leukemia as well as a promising prognostic indicator and therapeutic target.
Bruceine A inhibits TGF-β1/Smad pathway in pulmonary fibrosis by blocking gal3/TGF-β1 interaction.
Galectin-1 Regulates Inflammatory Responses and Promotes Microglial M2 Polarization in Chronic Migraine.
Gal-1 promotes lung cancer cell survival by enhancing PARP1/H1.2 interaction to promote DNA repair upon DNA damage response.
Galectin-3-integrin α5β1 phase separation disrupted by advanced glycation end-products impairs diabetic wound healing in rodents.
Acridine-Based Chalcone 1C and ABC Transporters.
Gal-1-mediated cytochrome p450 activation promotes fibroblast into myofibroblast differentiation in pulmonary fibrosis.
Galectin-receptor interaction: a key player in liver fibrosis induced by Schistosoma japonicum infection.
Clinicopathological differences between EGFR mutated and EGFR wild-type lung adenocarcinoma with papillary predominant pattern.
Distinct immune escape and microenvironment between RG-like and pri-OPC-like glioma revealed by single-cell RNA-seq analysis.
Oxidized galectin-1 in SLE fails to bind the inhibitory receptor VSTM1 and increases reactive oxygen species levels in neutrophils.
Testosterone attenuates senile cavernous fibrosis by regulating TGFβR1 and galectin-1 signaling pathways through miR-22-3p.
LGALS1 regulates cell adhesion to promote the progression of ovarian cancer.
Biomimetic nanoparticles drive the mechanism understanding of shear-wave elasticity stiffness in triple negative breast cancers to predict clinical treatment.
An Integrated Proteomics and Metabolomics Strategy for the Mechanism of Calcium Oxalate Crystal-Induced Kidney Injury.
Prognostic Value and Biological Function of Galectins in Malignant Glioma.
Mesenchymal stem cells target microglia via galectin-1 production to rescue aged mice from olfactory dysfunction.
Exosomal miR-22-3p from Mesenchymal Stem Cells Inhibits the Epithelial-Mesenchymal Transition (EMT) of Melanoma Cells by Regulating LGALS1.
Gasdermin D maintains bone mass by rewiring the endo-lysosomal pathway of osteoclastic bone resorption.
Galectin‑1 binds GRP78 to promote the proliferation and metastasis of gastric cancer.
Circular RNA RBPMS inhibits bladder cancer progression via miR-330-3p/RAI2 regulation.
Rosmarinic acid exerts a neuroprotective effect on spinal cord injury by suppressing oxidative stress and inflammation via modulating the Nrf2/HO-1 and TLR4/NF-κB pathways.
Nuclear FAM289-Galectin-1 interaction controls FAM289-mediated tumor promotion in malignant glioma.
Hepatocellular Carcinomas Originate Predominantly from Hepatocytes and Benign Lesions from Hepatic Progenitor Cells.
Global secretome characterization of A549 human alveolar epithelial carcinoma cells during Mycoplasma pneumoniae infection.
Tomioka S, Kitazawa R, Haraguchi R, Takaoka Y, Inoue A, Kitazawa S
Acta histochemica et cytochemica 2026 Feb 27;59(1):1-11
Acta histochemica et cytochemica 2026 Feb 27;59(1):1-11
Cancer-associated fibroblasts promote immune evasion in pancreatic cancer via miR-181b-5p/STING/LGALS1 pathway.
Zhang S, Guo Y, Qi H, Wu M, Hu Y, Lv G, Ye Y, Han J, Zeng Q, Du Y, Xu B, Liu M
Cancer letters 2026 Apr 28;644:218331
Cancer letters 2026 Apr 28;644:218331
Multi-omics analysis identified LGALS1 (Galectin-1) as a novel therapeutic target for clear cell renal cell carcinoma via targeting epithelial or endothelial cells.
Tan X, Chen Y, Jiang C, Shao J, Wang X
Discover oncology 2025 Oct 15;16(1):1894
Discover oncology 2025 Oct 15;16(1):1894
Molecular landscape of atherosclerotic plaque progression: insights from proteomics, single-cell transcriptomics and genomics.
Wang C, Feng Y, Liu X, Sun H, Guo Z, Shao J, Li K, Chen J, Shu K, Kong D, Wang J, Li Y, Lei X, Li C, Liu B, Sun W, Lai Z
BMC medicine 2025 May 1;23(1):254
BMC medicine 2025 May 1;23(1):254
Impact of galectin-1's redox state on its lectin activity and monomer-dimer equilibrium. Focusing on oxidized Gal-1.
Staroňová T, Holčáková J, Voňka P, Hrstka R, Ostatná V
International journal of biological macromolecules 2025 Mar;295:139452
International journal of biological macromolecules 2025 Mar;295:139452
Galectin-1: An important regulator in myeloid differentiation and acute myeloid leukemia as well as a promising prognostic indicator and therapeutic target.
Liu L, Cheng P, Cui J, Ren S, Yao M, Li L, Zhou H, Zhang X, Qin X, Liu Y, Zhang H, Wang L, Chen M
International immunopharmacology 2025 Jun 17;158:114835
International immunopharmacology 2025 Jun 17;158:114835
Bruceine A inhibits TGF-β1/Smad pathway in pulmonary fibrosis by blocking gal3/TGF-β1 interaction.
Du C, Ma C, Geng R, Wang X, Wang X, Yang J, Hu J
Phytomedicine : international journal of phytotherapy and phytopharmacology 2025 Jan;136:156267
Phytomedicine : international journal of phytotherapy and phytopharmacology 2025 Jan;136:156267
Galectin-1 Regulates Inflammatory Responses and Promotes Microglial M2 Polarization in Chronic Migraine.
Xiao Y, Han W, Yu M, Jiang J, Zhu Y
The European journal of neuroscience 2025 Feb;61(3):e70010
The European journal of neuroscience 2025 Feb;61(3):e70010
Gal-1 promotes lung cancer cell survival by enhancing PARP1/H1.2 interaction to promote DNA repair upon DNA damage response.
Chen Y, Liu X, Li B, Xie X, Xia J, Sun H
The FEBS journal 2025 Dec;292(23):6211-6232
The FEBS journal 2025 Dec;292(23):6211-6232
Galectin-3-integrin α5β1 phase separation disrupted by advanced glycation end-products impairs diabetic wound healing in rodents.
Zhang Z, Zhao Z, Huang X, Zhou L, Jiang X, Wu H, Liu C, Huang K, Wen J, Liu Y, Miller MC, Zhao Z, He Z, Wang Y, Liu S, Huang L, Yuan L, Zeng R, Cen Z, Chen A, Chen Y, Zeng G, Liu W, Hong X, Ren M, Yan L, Zhang Y, Guan D, Tian X, Cai W, Tai G, Mayo KH, Zhou Y, Li Z, Chen S
Nature communications 2025 Aug 7;16(1):7287
Nature communications 2025 Aug 7;16(1):7287
Acridine-Based Chalcone 1C and ABC Transporters.
Franko O, Čižmáriková M, Kello M, Michalková R, Wesołowska O, Środa-Pomianek K, Marques SM, Bednář D, Háziková V, Liška TJ, Habalová V
International journal of molecular sciences 2025 Apr 27;26(9)
International journal of molecular sciences 2025 Apr 27;26(9)
Gal-1-mediated cytochrome p450 activation promotes fibroblast into myofibroblast differentiation in pulmonary fibrosis.
Weng J, Cheng Q, Yang J, Jin H, Zhang R, Guan J, Ma Y, Wang L, Chen C, Wang Z
International immunopharmacology 2024 Nov 15;141:112920
International immunopharmacology 2024 Nov 15;141:112920
Galectin-receptor interaction: a key player in liver fibrosis induced by Schistosoma japonicum infection.
Huang Z, Liu X, Huang S, Lu F
Parasites & vectors 2024 May 20;17(1):232
Parasites & vectors 2024 May 20;17(1):232
Clinicopathological differences between EGFR mutated and EGFR wild-type lung adenocarcinoma with papillary predominant pattern.
Goto E, Taki T, Nomura K, Miyakami Y, Miyoshi T, Tane K, Samejima J, Aokage K, Nagamine M, Sakashita S, Sakamoto N, Kojima M, Suzuki K, Tsuboi M, Ishii G
Lung cancer (Amsterdam, Netherlands) 2024 Jun;192:107830
Lung cancer (Amsterdam, Netherlands) 2024 Jun;192:107830
Distinct immune escape and microenvironment between RG-like and pri-OPC-like glioma revealed by single-cell RNA-seq analysis.
Xian W, Asad M, Wu S, Bai Z, Li F, Lu J, Zu G, Brintnell E, Chen H, Mao Y, Zhou G, Liao B, Wu J, Wang E, You L
Frontiers of medicine 2024 Feb;18(1):147-168
Frontiers of medicine 2024 Feb;18(1):147-168
Oxidized galectin-1 in SLE fails to bind the inhibitory receptor VSTM1 and increases reactive oxygen species levels in neutrophils.
Jiang X, Xiao X, Li H, Gong Y, Wang M, Yang H, Zhao L, Jiang Y, Wei Y, Zhao C, Li J, Chen Y, Feng S, Deng H, Ma S, Xu Y, Liu Y, Tsokos GC, Jiang M, Zhang X
Cellular & molecular immunology 2023 Nov;20(11):1339-1351
Cellular & molecular immunology 2023 Nov;20(11):1339-1351
Testosterone attenuates senile cavernous fibrosis by regulating TGFβR1 and galectin-1 signaling pathways through miR-22-3p.
Hu Z, Zhang Y, Chen J, Luo M, Wang N, Xiao Y, He Q
Molecular and cellular biochemistry 2023 Aug;478(8):1791-1802
Molecular and cellular biochemistry 2023 Aug;478(8):1791-1802
LGALS1 regulates cell adhesion to promote the progression of ovarian cancer.
Li X, Wang H, Jia A, Cao Y, Yang L, Jia Z
Oncology letters 2023 Aug;26(2):326
Oncology letters 2023 Aug;26(2):326
Biomimetic nanoparticles drive the mechanism understanding of shear-wave elasticity stiffness in triple negative breast cancers to predict clinical treatment.
Zheng D, Zhou J, Qian L, Liu X, Chang C, Tang S, Zhang H, Zhou S
Bioactive materials 2023 Apr;22:567-587
Bioactive materials 2023 Apr;22:567-587
An Integrated Proteomics and Metabolomics Strategy for the Mechanism of Calcium Oxalate Crystal-Induced Kidney Injury.
Gao S, Chao Y, Li N, Li H, Zhao H, Liu X, Chen W, Dong X
Frontiers in medicine 2022;9:805356
Frontiers in medicine 2022;9:805356
Prognostic Value and Biological Function of Galectins in Malignant Glioma.
Zhu H, Liu D, Cheng L, Liu J, Wang G, Li H, Zhang Y, Mi H, Zhang S, Shu K, Yu X
Frontiers in oncology 2022;12:834307
Frontiers in oncology 2022;12:834307
Mesenchymal stem cells target microglia via galectin-1 production to rescue aged mice from olfactory dysfunction.
Seo Y, Ahn JS, Shin YY, Oh SJ, Song MH, Kang MJ, Oh JM, Lee D, Kim YH, Lee BC, Shin TH, Kim HS
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2022 Sep;153:113347
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2022 Sep;153:113347
Exosomal miR-22-3p from Mesenchymal Stem Cells Inhibits the Epithelial-Mesenchymal Transition (EMT) of Melanoma Cells by Regulating LGALS1.
Chen Y, Fang Y, Li L, Luo H, Cao T, Tu B
Frontiers in bioscience (Landmark edition) 2022 Sep 29;27(9):275
Frontiers in bioscience (Landmark edition) 2022 Sep 29;27(9):275
Gasdermin D maintains bone mass by rewiring the endo-lysosomal pathway of osteoclastic bone resorption.
Li M, Yang D, Yan H, Tang Z, Jiang D, Zhang J, Chi Z, Nie W, Zhen W, Yu W, Chen S, Wang Z, Yu Q, Zhang X, Yang F, Fan S, Lin X, Wang D
Developmental cell 2022 Oct 24;57(20):2365-2380.e8
Developmental cell 2022 Oct 24;57(20):2365-2380.e8
Galectin‑1 binds GRP78 to promote the proliferation and metastasis of gastric cancer.
Zhang Q, Ali M, Wang Y, Sun QN, Zhu XD, Tang D, Wang W, Zhang CY, Zhou HH, Wang DR
International journal of oncology 2022 Nov;61(5)
International journal of oncology 2022 Nov;61(5)
Circular RNA RBPMS inhibits bladder cancer progression via miR-330-3p/RAI2 regulation.
Yang C, Mou Z, Zhang Z, Wu S, Zhou Q, Chen Y, Gong J, Xu C, Ou Y, Chen X, Dai X, Jiang H
Molecular therapy. Nucleic acids 2021 Mar 5;23:872-886
Molecular therapy. Nucleic acids 2021 Mar 5;23:872-886
Rosmarinic acid exerts a neuroprotective effect on spinal cord injury by suppressing oxidative stress and inflammation via modulating the Nrf2/HO-1 and TLR4/NF-κB pathways.
Ma Z, Lu Y, Yang F, Li S, He X, Gao Y, Zhang G, Ren E, Wang Y, Kang X
Toxicology and applied pharmacology 2020 Jun 15;397:115014
Toxicology and applied pharmacology 2020 Jun 15;397:115014
Nuclear FAM289-Galectin-1 interaction controls FAM289-mediated tumor promotion in malignant glioma.
Guo XR, Wu MY, Dai LJ, Huang Y, Shan MY, Ma SN, Wang J, Peng H, Ding Y, Zhang QF, Tang JM, Ruan XZ, Li DS
Journal of experimental & clinical cancer research : CR 2019 Sep 6;38(1):394
Journal of experimental & clinical cancer research : CR 2019 Sep 6;38(1):394
Hepatocellular Carcinomas Originate Predominantly from Hepatocytes and Benign Lesions from Hepatic Progenitor Cells.
Tummala KS, Brandt M, Teijeiro A, Graña O, Schwabe RF, Perna C, Djouder N
Cell reports 2017 Apr 18;19(3):584-600
Cell reports 2017 Apr 18;19(3):584-600
Global secretome characterization of A549 human alveolar epithelial carcinoma cells during Mycoplasma pneumoniae infection.
Li S, Li X, Wang Y, Yang J, Chen Z, Shan S
BMC microbiology 2014 Feb 7;14:27
BMC microbiology 2014 Feb 7;14:27
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- human liver tissue were subjected to SDS PAGE followed by western blot with 11858-1-AP(GAL1,LGALS1 antibody) at dilution of 1:500
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- The Galectin 1 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human Galectin 1. This antibody recognizes human,mouse,rat antigen. The Galectin 1 antibody has been validated for the following applications: ELISA, WB, IHC analysis.